Patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study

BACKGROUND: Long-acting injectable buprenorphine (LAIB) is a new treatment for opioid use disorder that has been introduced against an international policy backdrop of recovery and person-centred care. This paper explores the goals that people want to achieve from LAIB to identify potential implicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Neale, Joanne, Parkin, Stephen, Strang, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288705/
https://www.ncbi.nlm.nih.gov/pubmed/37349776
http://dx.doi.org/10.1186/s13011-023-00551-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288705/
https://www.ncbi.nlm.nih.gov/pubmed/37349776
http://dx.doi.org/10.1186/s13011-023-00551-0

Ejemplares similares